Skip to main content
. 2006 Apr;17(4):1593–1605. doi: 10.1091/mbc.E05-02-0100

Table 1.

SRA transport from the ER

Time (h) Treatment ER (cell no.) Total (%) PM (cell no.) Total (%)
0 Control (FCS) 823 80 214 20
Statin (FCS) 667 83 138 17
Control (LPDS) 594 83 120 17
Statin (LPDS) 883 83 178 17
2 Control (FCS) 165 20 692 80
Statin (FCS) 339 34 643 66
Control (LPDS) 143 19 592 81
Statin (LPDS) 752 70 327 30

Data are representative results from three independent experiments.

HHS Vulnerability Disclosure